ResearcherShimane UniversityNo recent work listed

Shunichi Kumakura

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5011032843. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper

Papers 2

Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis. Last author DOI 10.3892/ijo.2018.4259 ↗
Combined treatment with cotylenin A and phenethyl isothiocyanate induces strong antitumor activity mainly through the induction of ferroptotic cell death in hu… Last author DOI 10.3892/or.2016.4867 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Takashi Kasukabe · 2 shared papers, 2016–2018 · strength 0.21
- Paper Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis. DOI 10.3892/ijo.2018.4259 ↗
- Paper Combined treatment with cotylenin A and phenethyl isothiocyanate induces strong antitumor activity mainly through the i… DOI 10.3892/or.2016.4867 ↗
Yuki Yamaguchi · 1 shared paper, 2018 · strength 0.14
- Paper Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis. DOI 10.3892/ijo.2018.4259 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.